Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases.
about
Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical TherapiesThe relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursorsHedgehog signaling pathway and its targets for treatment in basal cell carcinomaVitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteinsTazarotene induces apoptosis in human basal cell carcinoma via activation of caspase-8/t-Bid and the reactive oxygen species-dependent mitochondrial pathwayTazarotene as alternative topical treatment for onychomycosis.Basal cell carcinomas: attack of the hedgehog.Novel investigational therapies for onychomycosis: an update.Novel Hedgehog pathway targets against basal cell carcinoma.Efficacy and safety of topical tazarotene: a review.Novel investigational drugs for basal cell carcinoma.Advanced basal cell carcinoma.Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects.Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management.Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.Long-term establishment, characterization and manipulation of cell lines from mouse basal cell carcinoma tumors.PI3K-AKT signaling is a downstream effector of retinoid prevention of murine basal cell carcinogenesis.Extramammary Paget disease successfully treated with topical imiquimod 5% and tazarotene.
P2860
Q26744173-F85D2CD4-5BDE-4AFA-A809-0784054A9484Q26775913-176A3C63-4E8B-4FAD-9621-53ABEEA84904Q27021460-BF11CDCB-7AF7-478A-A8ED-27FC64A191A2Q28081177-5C70EA99-C298-4992-8CFC-5508A153BEEFQ34266288-D64323F2-27E0-4CBE-A18D-23A6C4D35FD6Q35113266-604E241C-FD3F-4379-9EF2-BD24A574C5CAQ35687900-BB577D7F-A658-4A0B-8C2E-076188DB6306Q35893705-EA3D504E-E609-4537-98D3-BD689A8081BDQ36727507-12A94261-CD51-40A1-8847-AA92834BAD3AQ37705240-3627A10C-15B7-42B4-9733-3DBC7FBA1E92Q37775962-DF1229C2-1F9B-47BF-A73F-2D413ADC339AQ38099285-DEAB8B13-C513-4DE3-B349-59627CB1800AQ38558092-C8A8D28F-F03B-494B-B891-C3A11D6E4830Q38602574-1648E766-D782-4EF2-810B-D8535F5B18A7Q39981775-0AD0AFDC-54D9-4955-A15E-4A6C8C882DE6Q40249166-C7F09B91-6A59-434E-A136-EFBC65094F66Q40355706-85A0653A-B279-4DAB-9F4C-0070A5824E87Q44681025-042B3378-8F35-4433-9C4C-C659886D4B7C
P2860
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Topical treatment of basal cel ...... dy on a large series of cases.
@en
Topical treatment of basal cel ...... dy on a large series of cases.
@nl
type
label
Topical treatment of basal cel ...... dy on a large series of cases.
@en
Topical treatment of basal cel ...... dy on a large series of cases.
@nl
prefLabel
Topical treatment of basal cel ...... dy on a large series of cases.
@en
Topical treatment of basal cel ...... dy on a large series of cases.
@nl
P2093
P2860
P1476
Topical treatment of basal cel ...... dy on a large series of cases.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2004.06044.X
P407
P577
2004-07-01T00:00:00Z